)
Cogstate (CGS) investor relations material
Cogstate AGM 2026 presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Financial performance review
FY26 sales contracts $89.0m, up 116%; 90 trial starts vs 35; contracted revenue $118.5m, including $48.3m for FY27, up 54%.
FY26 revenue $60.9m, up 15%; gross profit $35.4m at 58% margin, with 2H26 margin of 62%; PBT $16.1m, up 16%; cash $34.8m and no debt.
1Q27 net sales contracts $25.13m, up 17% YoY; nine new trials included four Phase 3 trials.
Contracted revenue reached $143.7m, with $56.8m expected to be recognised in FY27; FY28 contracted revenue was $39.7m.
Clinical trials backlog run-off totalled $132.3m at 30 September 2026, versus $107.1m at 30 June 2026.
Board and executive committee updates
Martyn Myer was Non-Executive Chairman; Brad O'Connor was Managing Director and CEO.
Ingrid Player chaired Audit, Risk & Compliance; Kim Wenn chaired Remuneration and Nomination; committee memberships also included Richard Mohs and Darryl Inns.
Dividend announcements
FY26 annual dividend increased to A$0.04 per share, fully franked; payout ratio was ~40% of after-tax profit, within the 20%–50% target range.
- $25.13m in Q1 contracts and 41% growth in contracted revenue, led by Phase 3 wins.CGS
Q1 2027 TU - Record FY26 revenue and profit growth driven by CNS trials, new indications, and tech investment.CGS
H2 2026 - FY26 sales contracts hit AUD 67.1m, driven by diversification and solution expansion.CGS
Status update - Revenue up 12% and net profit after tax up 16%, with record Clinical Trials contracts.CGS
H1 2026 - Record revenue, profit, and strategic expansion marked the year, with a maiden dividend declared.CGS
AGM 2025 - Record revenue, profit, and Medidata partnership drive expansion in CNS and digital trials.CGS
H2 2025 - Cogstate and Medidata's partnership accelerates CNS trial innovation with digital and AI solutions.CGS
Study Update - Profit before tax jumped 135% on 7% revenue growth, with strong cash flow and new IP control.CGS
H2 2024 - Record revenue and profit growth in 1H25, led by Clinical Trials and Medidata partnership.CGS
H1 2025
Next Cogstate earnings date
Next Cogstate earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)